Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb.

Edwards, Bryan B

Biochemically engineered stromal cell-derived factor 1-alpha analog increases perfusion in the ischemic hind limb. [electronic resource] - Journal of vascular surgery 10 2016 - 1093-9 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1097-6809

10.1016/j.jvs.2015.06.140 doi


Angiogenesis Inducing Agents--administration & dosage
Animals
Blood Flow Velocity
Chemokine CXCL12--administration & dosage
Disease Models, Animal
Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology
Hindlimb
Inflammation Mediators--metabolism
Injections, Intramuscular
Ischemia--drug therapy
Male
Neovascularization, Physiologic--drug effects
Protein Engineering
Quadriceps Muscle--blood supply
Rats, Wistar
Recombinant Proteins--pharmacology
Recovery of Function
Regional Blood Flow
Time Factors
Vascular Endothelial Growth Factor A--genetics